{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T18:32:09Z","timestamp":1779301929765,"version":"3.51.4"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"Innovative Medicines Initiative Joint Undertaking","award":["115523"],"award-info":[{"award-number":["115523"]}]},{"name":"Innovative Medicines Initiative Joint Undertaking","award":["115737"],"award-info":[{"award-number":["115737"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12879-017-2739-4","type":"journal-article","created":{"date-parts":[[2017,9,25]],"date-time":"2017-09-25T08:18:13Z","timestamp":1506327493000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Rationale and design of ASPIRE-ICU: a prospective cohort study on the incidence and predictors of Staphylococcus aureus and Pseudomonas aeruginosa pneumonia in the ICU"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5713-7652","authenticated-orcid":false,"given":"Fleur P.","family":"Paling","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darren P. R.","family":"Troeman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Wolkewitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rubana","family":"Kalyani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dani\u00ebl R.","family":"Prins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne","family":"Weber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Lammens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leen","family":"Timbermont","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herman","family":"Goossens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Surbhi","family":"Malhotra-Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frangiscos","family":"Sifakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc J. M.","family":"Bonten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan A. J. W.","family":"Kluytmans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,9,25]]},"reference":[{"key":"2739_CR1","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1164\/ajrccm.165.7.2105078","volume":"165","author":"J Chastre","year":"2002","unstructured":"Chastre J, Fagon J-Y. Ventilator-associated pneumonia. Am J Respir Crit Care Med American Thoracic SocietyNew York, NY. 2002;165:867\u2013903. doi:\n10.1164\/ajrccm.165.7.2105078\n\n.","journal-title":"Am J Respir Crit Care Med American Thoracic SocietyNew York, NY"},{"key":"2739_CR2","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1001\/jama.1995.03530080055041","volume":"274","author":"JL Vincent","year":"1995","unstructured":"Vincent JL, Bihari DJ, Suter PM, Bruining HA, White J, Nicolas-Chanoin MH, et al. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European prevalence of infection in intensive care (EPIC) study. EPIC international advisory committee. JAMA. 1995;274:639\u201344. Available: \nhttp:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7637145\n\n.","journal-title":"JAMA"},{"key":"2739_CR3","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1097\/QCO.0000000000000249","volume":"29","author":"IS Douglas","year":"2016","unstructured":"Douglas IS. New diagnostic methods for pneumonia in the ICU. Curr Opin Infect Dis. 2016;29:197\u2013204. doi:\n10.1097\/QCO.0000000000000249\n\n.","journal-title":"Curr Opin Infect Dis"},{"key":"2739_CR4","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.1007\/s00134-016-4339-y","volume":"42","author":"B Fran\u00e7ois","year":"2016","unstructured":"Fran\u00e7ois B, Jafri HS, Bonten M. Alternatives to antibiotics. Intensive Care Med. 2016;42:2034\u20136. doi:\n10.1007\/s00134-016-4339-y\n\n.","journal-title":"Intensive Care Med"},{"key":"2739_CR5","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1128\/AAC.02190-13","volume":"58","author":"L Hua","year":"2014","unstructured":"Hua L, Hilliard JJ, Shi Y, Tkaczyk C, Cheng LI, Yu X, et al. Assessment of an anti-alpha-toxin monoclonal antibody for prevention and treatment of Staphylococcus Aureus-induced pneumonia. Antimicrob agents Chemother. Am Soc Microbiol (ASM). 2014;58:1108\u201317. doi:\n10.1128\/AAC.02190-13\n\n.","journal-title":"Am Soc Microbiol (ASM)"},{"key":"2739_CR6","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1084\/jem.20120033","volume":"209","author":"A DiGiandomenico","year":"2012","unstructured":"DiGiandomenico A, Warrener P, Hamilton M, Guillard S, Ravn P, Minter R, et al. Identification of broadly protective human antibodies to Pseudomonas Aeruginosa exopolysaccharide Psl by phenotypic screening. J Exp Med. 2012;209:1273\u201387. doi:\n10.1084\/jem.20120033\n\n.","journal-title":"J Exp Med"},{"key":"2739_CR7","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1093\/jac\/dkv339","volume":"71","author":"T Kostyanev","year":"2016","unstructured":"Kostyanev T, Bonten MJM, O\u2019Brien S, Steel H, Ross S, Fran\u00e7ois B, et al. The innovative medicines Initiative\u2019s new drugs for bad bugs programme: European public-private partnerships for the development of new strategies to tackle antibiotic resistance. J Antimicrob Chemother Oxford University Press. 2016;71:290\u20135. doi:\n10.1093\/jac\/dkv339\n\n.","journal-title":"J Antimicrob Chemother Oxford University Press"},{"key":"2739_CR8","doi-asserted-by":"publisher","first-page":"S46","DOI":"10.1093\/cid\/ciw245","volume":"63","author":"B Fran\u00e7ois","year":"2016","unstructured":"Fran\u00e7ois B, Chastre J, Eggiman P, Laterre P-F, Torres A, Sanchez M, et al. The SAATELLITE and EVADE clinical studies within the COMBACTE consortium: a public\u2013private collaborative effort in designing and performing clinical trials for novel antibacterial drugs to prevent Nosocomial pneumonia: table 1. Clin Infect Dis. 2016;63:S46\u201351. doi:\n10.1093\/cid\/ciw245\n\n.","journal-title":"Clin Infect Dis"},{"key":"2739_CR9","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.cmi.2016.09.022","volume":"23","author":"FP Paling","year":"2017","unstructured":"Paling FP, Wolkewitz M, LGM B, PMC KK, DSY O, Depuydt P, et al. Staphylococcus Aureus colonization at ICU admission as a risk factor for developing S. Aureus ICU pneumonia. Clin Microbiol Infect. 2017;23:49.e9-49.e14. doi:\n10.1016\/j.cmi.2016.09.022\n\n.","journal-title":"Clin Microbiol Infect"},{"key":"2739_CR10","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/S1473-3099(05)70295-4","volume":"5","author":"HFL Wertheim","year":"2005","unstructured":"Wertheim HFL, Melles DC, Vos MC, van Leeuwen W, van Belkum A, Verbrugh HA, et al. The role of nasal carriage in Staphylococcus Aureus infections. Lancet Infect Dis. 2005;5:751\u201362. doi:\n10.1016\/S1473-3099(05)70295-4\n\n.","journal-title":"Lancet Infect Dis"},{"key":"2739_CR11","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1097\/CCM.0b013e3182a66bb8","volume":"42","author":"PD Ziakas","year":"2014","unstructured":"Ziakas PD, Anagnostou T, Mylonakis E. The prevalence and significance of methicillin-resistant Staphylococcus Aureus colonization at admission in the general ICU setting: a meta-analysis of published studies. Crit Care Med. 2014;42:433\u201344. doi:\n10.1097\/CCM.0b013e3182a66bb8\n\n.","journal-title":"Crit Care Med"},{"key":"2739_CR12","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1086\/422997","volume":"39","author":"KA Davis","year":"2004","unstructured":"Davis KA, Stewart JJ, Crouch HK, Florez CE, Hospenthal DR. Methicillin-resistant Staphylococcus Aureus (MRSA) nares colonization at hospital admission and its effect on subsequent MRSA infection. Clin Infect Dis. 2004;39:776\u201382. doi:\n10.1086\/422997\n\n.","journal-title":"Clin Infect Dis"},{"key":"2739_CR13","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1097\/CCM.0000000000000510","volume":"42","author":"MH Kollef","year":"2014","unstructured":"Kollef MH, Chastre J, Fagon J-Y, Fran\u00e7ois B, Niederman MS, Rello J, et al. Global prospective epidemiologic and surveillance study of ventilator-associated pneumonia due to Pseudomonas Aeruginosa. Crit Care Med. 2014;42:2178\u201387. doi:\n10.1097\/CCM.0000000000000510\n\n.","journal-title":"Crit Care Med"},{"issue":"Suppl 6","key":"2739_CR14","doi-asserted-by":"publisher","first-page":"G38","DOI":"10.1016\/j.vaccine.2009.09.105","volume":"27","author":"C Saylor","year":"2009","unstructured":"Saylor C, Dadachova E, Casadevall A. Monoclonal antibody-based therapies for microbial diseases. Vaccine. 2009;27(Suppl 6):G38\u201346. doi:\n10.1016\/j.vaccine.2009.09.105\n\n.","journal-title":"Vaccine"},{"key":"2739_CR15","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","volume":"310","author":"World Medical Association","year":"2013","unstructured":"World Medical Association. World medical association declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310:2191\u20134. doi:\n10.1001\/jama.2013.281053\n\n.","journal-title":"JAMA"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-017-2739-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,9,25]],"date-time":"2017-09-25T08:18:21Z","timestamp":1506327501000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-017-2739-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,25]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["2739"],"URL":"https:\/\/doi.org\/10.1186\/s12879-017-2739-4","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,25]]},"article-number":"643"}}